Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001012975-19-000041
Filing Date
2019-01-04
Accepted
2019-01-04 17:22:06
Documents
1
Period of Report
2019-01-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3922
  Complete submission text file 0001012975-19-000041.txt   5457
Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
SAYARE MITCHEL (Reporting) CIK: 0001201196 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32587 | Film No.: 19511164

Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations